← Every company
Abbott Laboratories Patents
What Abbott Laboratories has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
ABT on carbonthat →Filings on file
56
Granted
0
Still pending
56
Filed under
2 names
56 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| MAGNETIC POINT-OF-CARE SYSTEMS AND ASSAYS FOR DETERMINING GFAP IN BIOLOGICAL SAMPLESG01N 33/54333, G01N 33/6893, G01N2470/04, G01N 33/54326, G01N 33/54386, G01N 33/6896, G01N2333/4756, G01N2800/2871Filed as Abbott Laboratories2026-06-18Antti Virtanen | pending |
| METHODS FOR DETECTING ROCAHEPEVIRUSG01N 33/56983, G01N2333/08, G01N2469/20Filed as Abbott Laboratories2026-03-31Michael G. Berg | pending |
| UNCLEAVABLE AMH VARIANT POLYPEPTIDES AND USES THEREOFFiled as ABBOTT LABORATORIES2026-03-23LICI A. SCHURIG BRICCIO | pending |
| METHODS OF DETECTING VARIANT NUCLEIC ACIDSC12Q 1/703, C12Q 1/6806, C12Q 1/6827, C12Q 1/6844Filed as ABBOTT LABORATORIES2026-02-27Andrew Morris | pending |
| NUTRITIONAL COMPOSITION HAVING LIPOPHILIC COMPOUNDS WITH IMPROVED SOLUBILITY AND BIOAVAILABILITYA23L 33/115, A23L 33/17, A23L 33/19, A23L 33/15, A23L 33/40, A23L 33/155, A61P 3/02, A23C 9/1526, A23C 9/1528, A23V2002/00, A23V2250/182, A23V2250/192, A23V2250/211, A23V2250/71Filed as Abbott Laboratories2026-02-18Paul Johns | pending |
| COMPOSITIONS AND METHODS FOR DETECTING INFLUENZA A VIRUS SUBTYPE H5N1Filed as ABBOTT LABORATORIES2026-02-13LESTER J. PEREZ | pending |
| NUTRITIONAL COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES AND NUCLEOTIDES AND USES THEREOF FOR TREATING AND/OR PREVENTING ENTERIC VIRAL INFECTIONA61K 31/702, A23L 33/13, A23L 33/125, A23L 33/40, A61P 31/12, A61P 1/12, A23C 9/1526, A23C 9/156, A23V2002/00, A23V2200/32, A23V2200/3202, A23V2200/324, A23V2250/284, A61K 31/7008, A61K 31/7012, A61K 31/7016, A61K 31/7068, A61K 31/7072, A61K 31/7076, A61K 31/708, A61K2300/00, A23V2200/02, A23V2250/18, A23V2250/612, A23V2250/54252, A23V2250/5036, A23V2250/156, A23V2250/032, A23V2250/211, A23V2250/70Filed as ABBOTT LABORATORIES2026-02-11Rachael Buck | pending |
| METHODS AND COMPOSITIONS FOR MAINTAINING SKELETAL MUSCLE MOBILITY AND/OR MASS, AND/OR FOR RECOVERY OF SKELETAL MUSCLE STRENGTHFiled as ABBOTT LABORATORIES2026-01-29Manuel Manzano | pending |
| SYSTEMS AND METHODS FOR TBI ADJUDICATIONFiled as ABBOTT LABORATORIES2025-11-24BETH MCQUISTON | pending |
| AUTOMATED ASSAY PROCESSING UNITFiled as ABBOTT LABORATORIES2025-11-07JASON N. HARRIS | pending |
| METHODS FOR DETECTING AND DISTINGUISHING TREPONEMA PALLIDUM SUBSPECIES AND USES THEREOFFiled as ABBOTT LABORATORIES2025-11-05LESTER PEREZ | pending |
| VACUUM-OPERATED SYSTEMS AND METHODS FOR HANDLING OBJECTSFiled as ABBOTT LABORATORIES2025-10-27PATRICK P. FRITCHIE | pending |
| HIGH-SENSITIVITY DIAGNOSTIC TEST DEVICES AND METHODS AND APPARATUS TO MAKE AND/OR PROCESS THE SAMEFiled as ABBOTT LABORATORIES2025-09-03TORU YOSHIMURA | pending |
| METHODS, COMPOSITIONS, AND KITS FOR TARGET ENRICHMENT AND METAGENOMIC NEXT GENERATION SEQUENCINGFiled as ABBOTT LABORATORIES2025-08-27MICHAEL BERG | pending |
| SYSTEMS AND METHODS FOR DIAGNOSING OR AIDING IN THE DIAGNOSIS OF A TBIFiled as Abbott Laboratories2025-08-20Beth McQuiston | pending |
| BETAINE AND FOLATE FOR PROMOTING INFANT BRAIN MATURATIONFiled as ABBOTT LABORATORIES2025-08-08JIA PEI CHAN | pending |
| SYSTEMS AND METHODS FOR DETERMINING BIOMARKERS IN BLOOD SAMPLESFiled as ABBOTT LABORATORIES2025-07-22MICKEY URDEA | pending |
| SYSTEMS AND METHODS FOR DETERMINING BIOMARKERS IN BLOOD SAMPLESFiled as ABBOTT LABORATORIES2025-07-22MICKEY URDEA | pending |
| SYSTEMS AND METHODS FOR DIGITAL DETECTION ASSAYSFiled as ABBOTT LABORATORIES2025-07-22PETER KARABATSOS | pending |
| SAMPLE TUBES FOR BIOLOGICAL FLUIDSFiled as ABBOTT LABORATORIES2025-07-18TIMOTHY PLETCHER | pending |
| NUTRITIONAL FORMULATIONS FOR PROMOTING HEALTHY GUT MICROBIOTA AND FUNCTIONFiled as ABBOTT LABORATORIES2025-07-01SINÉAD T. MORRIN | pending |
| METHODS OF DETERIMING AND PREDICTING THE EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR TREATMENT IN SUBJECTS WITH HEPATOCELLULAR CARCINOMAFiled as ABBOTT LABORATORIES2025-07-01TARO YAMASHITA | pending |
| AMPLIFICATION VESSELFiled as ABBOTT LABORATORIES2025-06-23PATRICK FRITCHIE | pending |
| TUB AND DECK ASSEMBLYFiled as ABBOTT LABORATORIES2025-06-23PATRICK FRITCHIE | pending |
| MACHINE VISION SYSTEMS AND METHODS FOR DETERMINING ATTRIBUTES OF A CONTAINER IN A DIGITAL IMAGE AND DETECTING PRESENCE OF CAPPED TUBES IN A DIAGNOSTIC INSTRUMENTFiled as ABBOTT LABORATORIES2025-06-17BY-HER RICHARDS | pending |
| INDUCTIVE HEATING SYSTEMS AND METHODS OF CONTROLLING THE SAME TO REDUCE BIOLOGICAL CARRYOVERA61L 2/04, H05B 6/10, H05B 6/108, A61L 2/24, A61L2202/14, G01N 35/1004, H05B 6/06, H05B 6/101, H05B 6/14, H05B 6/36, H05B 6/40Filed as Abbott Laboratories2025-06-12Patrick Fritchie | pending |
| MACHINE VISION INVENTORY VERIFICATION OF CONSUMABLES IN MEDICAL DIAGNOSTIC INSTRUMENTSFiled as ABBOTT LABORATORIES2025-06-11BY-HER RICHARDS | pending |
| METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS IN INFANTS, TODDLERS, OR CHILDREN USING HUMAN MILK OLIGOSACCHARIDESA61K 31/702, A23L 33/10, A23L 33/12, A23L 33/19, A23L 33/30, A23L 33/135, A23L 33/40, A23V2002/00, A61K 9/107, A61K 31/716, A61K 31/733, A61K 35/20, A61K 35/744, A61K 35/745, A61K 35/747, A61K 36/48, A61K 38/018, A61K 45/06, A61K2035/11, A61K2035/115, A61K2300/00, A23V2200/32, A23V2250/282Filed as ABBOTT LABORATORIES2025-05-28JoMay Chow | pending |
| METHODS AND COMPOSITIONS FOR SLOWING DIABETES DEVELOPMENT OF REDUCING A RISK OF DIABETESA61K 35/745, A23L 33/125, A23L 33/21, A23L 33/135, A61P 3/10, A61K 31/7004, A61K 31/7016, A61K 31/718, A61K2300/00Filed as Abbott Laboratories2025-05-19José María López Pedrosa | pending |
| REAGENT COMPOSITIONS FOR ISOTHERMAL AMPLIFICATION OF NUCLEIC ACIDSFiled as ABBOTT LABORATORIES2025-05-14JAMIE ABBOTT | pending |
| METHODS OF IDENTIFYING MACROTROPONIN IN BIOLOGICAL SAMPLESG01N 33/6878, G01N 33/6887, G01N2333/4712Filed as Abbott Laboratories2025-05-01John C. Prostko | pending |
| IMPROVED METHODS FOR DETERMINING CARDIAC MYOSIN BINDING PROTEIN C IN BIOLOGICAL SAMPLESFiled as ABBOTT LABORATORIES2025-04-28JOHN PROSTKO | pending |
| MACHINE VISION INVENTORY VERIFICATION OF CONSUMABLES IN MEDICAL DIAGNOSTIC INSTRUMENTSFiled as Abbott Laboratories2025-04-22By-Her Richards | pending |
| CARTRIDGES FOR ANALYZING CELLS AND METHODS OF USING THEMFiled as ABBOTT LABORATORIES2025-04-11TIMOTHY PLETCHER | pending |
| METHODS AND APPARATUS TO REDUCE ANXIETY WITH MIXED REALITYG06T 19/006, G02B 27/017, G02B2027/0178, G06F 3/013, G06F 3/167, G06T 13/40Filed as Abbott Laboratories2025-04-10Miguel Carrazza Morales | pending |
| METHODS FOR DETECTING ROCAHEPEVIRUSFiled as Abbott Laboratories2025-04-01Michael G. Berg | pending |
| METHODS OF USING HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING AIRWAY RESPIRATORY HEALTHA61K 31/702, A23L 33/40, A61P 39/06, A61P 31/00, A61P 31/12, A61P 11/00, A23C 9/206, A23V2002/00, A61K 31/716, A61K2300/00, A23V2200/324, A23V2250/282Filed as ABBOTT LABORATORIES2025-03-27RACHAEL BUCK | pending |
| UNCLEAVABLE AMH CALIBRATOR AND USES THEREOFFiled as Abbott Laboratories2025-03-21Lici A. Schurig Briccio | pending |
| TECHNOLOGY TO AUTOMATICALLY IDENTIFY THE MOST RELEVANT HEALTH FAILURE RISK FACTORSG16H 50/30, G16H 50/20, G06N 20/00Filed as Abbott Laboratories2025-03-19Divine E. EDIEBAH | pending |
| DIAGNOSIS AND MONITORING OF LIVER DISEASEFiled as ABBOTT LABORATORIES2025-03-12GERARD DAVIS | pending |
| SAMPLE FLUID ANALYSIS DEVICES, CARTRIDGES FOR USE THEREIN, AND METHODS OF USE THEREOFFiled as ABBOTT LABORATORIES2025-03-07YANG ZHANG | pending |
| LIGHT INTERROGATION SYSTEMS HAVING FIRST AND SECOND PINHOLE PLATES, AND METHODS OF USE THEREOFFiled as ABBOTT LABORATORIES2025-03-07YANG ZHANG | pending |
| SYNTHESIS OF THYROID HORMONE DERIVATIVES AND THEIR ROLE AS CALIBRATORS FOR THYROID HORMONE IMMUNOASSAYSFiled as ABBOTT LABORATORIES2025-03-06RAHUL D. PATIL | pending |
| USE OF CARDIAC TROPONIN AND GALECTIN-3 TO DIFFERENTIATE MYOCARDIAL INFARCTION TYPE I AND TYPE IIG16H 50/20, G16H 20/10, G16H 20/40, G16H 40/67, G16H 10/60, G16H 50/30, G01N2800/324, G01N2800/60Filed as Abbott Laboratories2025-02-18Gillian Murtagh | pending |
| COMPOSITIONS AND METHODS FOR DETECTING INFLUENZA A VIRUS SUBTYPE H5N1Filed as Abbott Laboratories2025-02-14Lester J. Perez | pending |
| ASSAYS FOR DETECTING MONKEYPOX VIRUSC12Q 1/701, C12Q 1/6888, C12Q2600/16, C12Q2600/166Filed as Abbott Laboratories2025-01-29Gavin Cloherty | pending |
| METHODS AND SYSTEMS FOR MALIGNANCY PREDICTION OF INDETERMINATE PULMONARY NODULESG16H 50/30, G16H 10/60, G16H 50/70Filed as Abbott Laboratories2025-01-09Gerard J. Davis | pending |
| METHODS AND SYSTEMS FOR DIAGNOSING ORTHOPOXVIRUS INFECTIONG01N 33/6854, G01N 33/543, G01N 33/577, G01N2469/20, G01N2800/26Filed as Abbott Laboratories2025-01-07Abbas X. Hadji | pending |
| HBV DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC METHODS AND PRODUCTSG01N 33/5764, C12Q 1/48, C12Q 1/6837, G01N 33/5762, G01N2800/52, G01N2800/54, C12N 9/1096, A61K 31/513, A61K 31/522, A61K 31/675, A61K 31/7072, A61K 31/711, A61K 31/713, A61K 38/212, C12Q 1/706, C12Q2600/106, C12Q2600/112, C12Q2600/118, C12Q2600/158, C12Y 206/01001, C12Y 206/01002, G01N 33/5761, G01N2800/56Filed as Abbott Laboratories2024-12-31Gavin A. Cloherty | pending |
| METHODS, SYSTEMS, COMPOUNDS, AND KITS FOR DETERMINING AN ANALYTE OF INTEREST IN A TEST SAMPLEFiled as ABBOTT LABORATORIES2024-12-27QIAOQIAO RUAN | pending |
| BODILY FLUID SAMPLING DEVICESFiled as ABBOTT LABORATORIES2024-12-23ANDREW S. SCHAPALS | pending |
| REDUCING AGENT COMPOSITIONS FOR ISOTHERMAL AMPLIFICATION OF NUCLEIC ACIDSFiled as ABBOTT LABORATORIES2024-12-20ERIC HUNGATE | pending |
| DISPENSING REAGENT CONTAINERS AND METHODS OF DISPENSINGFiled as ABBOTT LABORATORIES2024-12-19ROBERT P. LUOMA | pending |
| DEVICES, SYSTEMS, AND METHODS FOR MAGNETIC-MICROPARTICLE MANIPULATIONFiled as ABBOTT LABORATORIES2024-12-19TOMOHIRO IKEDA | pending |
| REACTION VESSEL MOVING MEMBER FOR MOVING REACTION VESSELS FROM A PROCESSING TRACK TO A ROTATING DEVICE IN A DIAGNOSTIC ANALZYERG01N 35/04, G01N 35/021, G01N 35/025, G01N2035/0408, G01N2035/0443Filed as Abbott Laboratories2024-12-10Robert Luoma | pending |
| DROPLET ACTUATOR FABRICATION APPARATUS, SYSTEMS, AND RELATED METHODSB01L 3/50273, B01L 3/502738, B01L2400/0424, B01L2400/0427, B41J 2/06, G01N 27/44743, H05K 1/0269, H05K 1/0272, H05K 3/0097, H05K 3/027, H05K 3/388, H05K2201/09918, H05K2203/1173, H05K2203/1545, B41J 2/1623, B41J 2/16, B41J 2/1631, B41J 2/1632, B41J 2/1634, B41J 2/1635, B41J 2/1642, B41J 2/1645Filed as Abbott Laboratories2024-12-05Andrew Fischer | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on ABT
Company overviewEverything on ABT in one place, with the price.SEC filingsWhat ABT's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat ABT's own officers and directors buy and sell.Who owns itEvery manager reporting a position in ABT.Funds holding itWhich funds and ETFs hold ABT, and how big a bet.LobbyingWhat ABT spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ABT's account, and who they worked for.Federal contractsWhat federal agencies pay ABT.